Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3100 Plaza Properties Blvd
Columbus, OH 43219Phone+1 614-383-6000Fax+1 614-383-6001
Summary
- Dr. Hiral Shah is an oncologist in Mansfield, OH and is affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute. She received her medical degree from Northeast Ohio Medical University and has been in practice 7 years. She specializes in hematologic oncology and melanoma and is experienced in hematologic oncology.
Education & Training
- Northwestern Memorial HospitalDevelopmental Therapeutics Program, 2016 - 2017
- University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 2013 - 2016
- Loyola University Medical CenterResidency, Internal Medicine, 2010 - 2013
- Northeast Ohio Medical UniversityClass of 2010
Certifications & Licensure
- OH State Medical License 2017 - 2026
- CO State Medical License 2022 - 2025
- IL State Medical License 2010 - 2020
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 18 citationsEffect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma.Steven Sun, Brooke Benner, Himanshu Savardekar, Gabriella Lapurga, Logan Good
Frontiers in Immunology. 2021-10-12 - 108 citationsUpdates on immunotherapy for colorectal cancerAparna Kalyan, Sheetal Mehta Kircher, Hiral Shah, Mary F. Mulcahy, Al B. Benson
Journal of Gastrointestinal Oncology. 2018-07-02 - 14 citationsPhase I Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) in Combination With Selective VEGFR Inhibitor Pazopanib for Therapy of Advanced Solid Tumors.Hiral A. Shah, James H. Fischer, Neeta K. Venepalli, Oana Cristina Danciu, Sonia Christian
American Journal of Clinical Oncology. 2019-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: